Abstract:
ObjectiveTo analyze the influencing factors of frailty in maintenance hemodialysis (MHD) patients and establish a nomogram model for frailty risk.
MethodsA total of 222 patients with MHD were selected by convenient sampling method.According to whether the patients had frailty, they were divided into frailty group (n=85) and non-frailty group (n=137).Univariate and multivariate logistic regression model were used to screen the risk factors of frailty in patients with MHD.Bootstrap was used for internal verification of the model.The receiver operating characteristic (ROC) curve, Homster-Lemeshow goodness-of-fit test combined with calibration curve, and clinical decision curve analysis (DCA) were used to evaluate the performance of the model.
ResultsThere were 85 cases of frailty in 222 patients with MHD, and the incidence of frailty was 38.3%.Logistic regression analysis showed that age ≥60 years old (OR=3.454, 95%CI: 1.775-6.719), the number of dialysis complications (OR=1.609, 95%CI: 1.173-2.207), albumin level (OR=0.901, 95%CI: 0.835-0.971), physical exercise (OR=0.684, 95%CI: 0.564-0.829) and night sleep time (OR=0.476, 95%CI: 0.316-0.716) were independent risk factors of frailty in patients with MHD (P < 0.05 to P < 0.01).Based on five independent risk factors, the nomogram prediction model of frailty in MHD patients was established.The area under ROC curve was 0.829 (95%CI: 0.777-0.882).After internal verification by Bootstrap resampling method, the consistency index of the model was 0.812.The fitting degree of nomograph model was good (P>0.05).The calibration curve showed that the correlation between the predicted probability and the actual probability incidence was good.The DCA showed that the model had good clinical practicability when the threshold probability was 0.03-0.83.
ConclusionsThe prediction model based on the risk factors affecting the frailty of MHD patients has good differentiation, consistency and clinical practicability, and can provide guidance for the prevention of the frailty of MHD patients.